Hypoglycemia is the major barrier to good glycemic control in patients with diabetes mellitus. Furthermore, randomized controlled trials have emphasized the grave risks associated with severe ...

The tumor was resected with cure of symptoms. A 41-year-old Maltese woman was referred to a specialist center for evaluation of fasting hypoglycemia. The patient reported a 12-month history of ...

Nocturnal hypoglycemia refers to low blood glucose levels during sleeping. Regularly monitoring glucose levels and adjusting insulin dosages can help prevent nocturnal hypoglycemia. Nocturnal ...

Diazoxide, ¶ a nondiuretic benzothiadiazine, has been found to have definite hyperglycemic properties, and its use in various forms of hypoglycemia has been the subject of several reports. 11,13 ...

Reports of fluoroquinolone-induced hypoglycemia are abundant, but reports of hyperglycemia induced by fluoroquinolones are also available. [15–19] The primary theory of fluoroquinolone ...

Objective Hypoglycemia is a cause of significant morbidity among patients with diabetes and may be associated with greater risk of death. We conducted a retrospective study to determine whether ...

Phase 1 results support proceeding to Phase 2 in patients with post-bariatric hypoglycemia (PBH),which is expected to begin in 2H 2025Phase 1 ...

A new study published in the NEJM Evidence journal showed that automated insulin delivery reduced hypoglycemia in older ...

Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital ...

Pivotal Phase 3 LUCIDITY trial will evaluate FDA-agreed upon primary outcome of reduction in hypoglycemia events and designed to align as closely as possible with previous Phase 2 trial designs ...